Hepion Pharmaceuticals, Inc. financial statements
Hepion Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 8.28M | 10-K |
| Cash and equivalents | USD 1.83M | 10-Q/A |
Hepion Pharmaceuticals, Inc. financials on 6ix · Hepion Pharmaceuticals, Inc. on 6ix